eli lilly taking a little bit harder. they did come out with earnings. those shares down about 2%.this has to do with that covid therapy. sales in the recent quarter dropped to about $150 million, down from $800 million plus in the previous quarter. now the focus is going to be on the company's alzheimer's treatment which is still in development. you are still talking about $27 billion in annual revenue projected for the year ahead, but that is still a little bit like from what the street was expecting. clorox reported earnings. these shares down 8.5%. this company really got hit hard. they have benefited a lot from everybody disinfecting during the pandemic. sales came in way below estimates, and their estimated for a decline in sales for the fiscal year that just started in july. so this is a big deal. also keep an eye on take-two and the rest of the videogame space. take-two did report earnings. they also missed estimates in terms of revenue and in their monthly active users. this is a stock from a company that said they are delaying a couple of games. they didn't specify what t

they're the only company that doesn't have a government purchase order eli lilly and regeneron do they say the supply is plentiful. lilly's drug was paused in the united states because its combination wasn't working against some of the variants the fda says it works against the delta variant and now has been unpaused in the 22 yellow states where the variants are less prevalent these drugs getting a lot more use now in lower vaccinated areas. >> unfortunately friends of ours in florida, this is literally what's happened to them over the past couple of weeks i'm curious as people are starting to speculate about whether delta has quote/unquote peaked, what can you tell us about case count hospitalizations i suppose it's these people trying to find comfort as the numbers continue to spike. >> the numbers are scary, 100,000 people in the hospital right now with covid these are numbers we didn't expect to see again after the vaccines got started rolling out broadly. i have seen notes suggesting that at least the pace of the increases has been slowing, and that is some good news but it's not

in focus reports on factory orders and auto sales and earnings from eli lilly, dupont and marriott. pierson, the largest publisher of college textbooks is launching a service for digital books. it will be available on campuses this fall. students can pay $9.99 a month to access one textbook at a time or $14.99 for access to the full library of 1500 e-books and study aids like flash cards. it's going to cost you a little bit more to protect your breakables with bubble wrap. sealed air, that's the company that makes the iconic bubble wrap, and other packaging and shipping products, will increase prices from 5 to 10% in september. anywhere between that range. that's because of rising costs as well as inflation and a climate it actually expects to continue for some time, higher prices, so it's not something we want to hear but we're seeing that in a lot of our news reports as of late. >> really interesting. thanks. >>> coming up here on "today in the bay," meteorologist kari hall tracking those conditions on the foggy and cloudy morning in the city. >> little bit cooler heading out in n

more second quarter earnings reports are due out today, including from eli lilly, marriott and undergs reports have been strong with the average s&p 500 company reporting an 85% growth in profits from last year. stocks were mixed yesterday. the dow fell 97 points. the nasdaq added 8 points and the s&p 500 was down 8 points. >>> millions of people will have to mask up if they want to go to mcdonald's. the fast food chain is requiring facial coverings for customers and employ yes, sir in covid hot spots regardless of their vaccination status. the move is in response to the latest cdc guidance as the delta variant continues to spread in the u.s. mcdonald's continued back in may. >>> reese witherspoon's business empire is growing. hello sunshine is being sold to a media firm for a reported $900 million. witherspoon and her senior managers will continue to run the company which focuses on stories by and for women. it's helped produce tv shows including "the morning show," "big little lies" and "little fires everywhere." >>> disneyland is set to unveil a new magic key program which will re

>> more earnings looking at craft, eli lilly, the host of the retailers will come out and these are theompanies unlike the tech stocks that got all the focus is week of the ones that are on the ground and will tell us how consumers are spending and how business is going. jack: one more big number is the jobs numbers and we always look at this carefully but will look really carefully this week because we have all the job openings all the people unemployed are they going to meet each other, shake hands and will we see them on friday. >> exactly the number that we expected is in excess of a hundred thousand new jobs added in the month of july as you mentioned we have nine-point to million job openings yeah 9.5 million unemployed as you mentioned those aren't meeting and we would see a return of workers into the workforce in september but some of the hope is anticipating the proponent would say the enhanced unemployment benefits are expiring in schools are reopening that would free appearance to go back to the workforce but then you had the other situations such as the delta variant and ris

. >>> eli lilly. i don't think that's a real trade there. we'll see.company reported $6.74 billion versus $6.619 billion kind of interesting that the $1.87 the company earned versus $1.89 last year. the company is comfortable with adjusted earning per share year view of $7.80 to $8. the street is $7.90. that is three cents shy of last year drug companies have a lot they deal within terms of things going off patent and new medicines and everything else. it is not unusual to see a flat year or even a down year that's what we're looking at for this fiscal year the company also said that its covid therapy, the 2021 estimate of what it would get from covid-19 therapy, they are cutting that revenue from $1 million to $1.1 million. we will talk to david ricks of eli lilly. he joins us in the next hour in the first interview. we will look at where the stock is indicated the ask is down 10 cents from where it closed. becky. >>> thanks, joe. back to school season starts this month as we all found out last year, there are certain circumstances, including covid, t

they are available from regeneron, eli lilly and veer biotechnology along with glaxosmithkline. dr. could reduce hospitalization or death by 70 to 85% they are indicated for people over the age of 65 or who have health conditions that put them at high risk of severe disease these have been underutilized up to this point. even six weeks ago regeneron was shipping about 25,000 doses per week now that's gone up to more than 150,000 doses. hhs tells us that three quarters of the orders that they have seen since july 1st have come from areas of the country with lower v lower vaccination rates. the most from the region including florida. the second most coming from the region including texas we caught up with veer's ceo last week about what he is seeing in the trends right now >> antibodies, i think, finally are getting recognition that they deserve they really do reduce hospitalization and mortality dramatically the u.s., which had an oversupply for a while, has the potential now to have an undersupply. because of the tests -- [ inaudible ]. >> now, the u.s. government has made purchases

that includes, yes, the cocktail known as regeneron, the eli lilly version of regeneron. hydroxychloroquine,i every method, you get to decide but sadly the health experts andnd biden administration do not appear capable of providing clear, consistent and guidance on everywhere, it is flipping and flopping and flailing all over the place.si people rightly are getting angry, and they feel like they don't know this is a gang that can't shoot straight. they don't know what they are doing. last week the white house said that strict, vaccines mandates. wow, i didn't think that would happen but it did. the teachers unions interestingly they are coming out against the mandates. all of a sudden, it's not exactly clear where the biden administration stands on the issue.e. of course, democrats every election season, they rake in millions and millions of dollars from teachers unions. donate enough money, you can even dictate cdc policy as we have learned previously. make no mistake, vaccine mandates are a terrible idea just like vaccine and the principles of medical privacy. the medi

eli lilly and others going in that direction. tom: you saw the supreme court yesterday with that single vote saying no. indiana university, this is the way it is. jonathan: here is the direction of travel in this equity market. s&p 500, we advanced by .04%. nasdaq futures unchanged. crude down about 25%. -- .25%. lisa: there is not that much going on. it is a sleepy friday after a lot of people solidified very good years. if you are watching data to see if something could move the needle, 8:30 a.m., import-export prices. this highlights the increasing supply chains disruptions. we saw china partially closed down. what happens next? dry bulk costs are rising to the highest level in a long time. we also get to speak with the head of blackrock investment institute. he will talk about his outlook and whether he is willing to push against this bullish sentiment. the bulls have made money and the bears have been wrong. i confess. is there any reason to be skeptical in any way at this point? do you just succumb to this groundswell towar

eli lilly moving higher. lots of attention being paid.ewhere, other developments maybe not so positive. this is not falling off a cliff on speculation that u.k. authorities may hit pause on its acquisition of arm. amd moving higher potentially because of that. energy is the leader. growth starts -- stocks are the middle of the path. for what it's worth, be can't ignore the revelatory impact that keeps rolling in from china. the chinese government would like its own companies and perhaps investors around the world to remember that it is in charge. tencent bearing the brunt of this. it is hard not to imagine with this article talking about it being spiritual opium that there may not be additional follow-up. it is hard to tell exactly where this lands. matt: to me, it recalls a marxist, "religion is the opiate of the masses." in this case the chinese are saying do games or the opiate of the young masses. it is not just hitting hard in china. we see video game makers in the u.s. hit hard as well. take two down 10%. literally decimated. we tal

we hear from eli lilly, under armour in the next hour. >>> chinese gaming stocks hammered overnight igaming, perhaps, the next target because it is being called the opium of the mind in an article over there. >>> a closer look at the return to work for major companies as covid cases surge in the u.s it is tuesday, august 3rd, 2021. "squawk box" begins right now. >>> good morning welcome to "squawk box" here on cnbc i'm becky quick along with joe kernen and andrew ross sorkin. joe, you are right positive territory yesterday at this time. the dow actually set an all-time high early in the session before giving it all back and closing down 100 points. s&p was down this is four of five session

your estate once again to build that the use of monoclonal antibodies centers, regeneron centers, eli lillyters. so when people that are fully vaccinated or not get covid they can get the infusion of regeneron as quickly as possible and that will be available all throughout the state. you are in the process of doing it everywhere right now, is that correct? >> that's correct. we've already had a forest sites up and by the end of the week we will have 10-15. they will each be able to do ten or 20 treatments per day which is a lot. we will do thousands of these which are available every single day, and you and i know people. they took this, they had symptoms and it was resolved. it can keep you out of the hospital and save your life. if more people need to know about it and that's one of the reasons we are doing the centers so that people understand if you are covid positive you have the ability to do early treatment which is great. >> sean: and that has probably been the most under therapeutic out there. our friend governor abbott is in our prayers tonight and i know he had the infusion hims

eli lilly missed on profit, but shares are holding up. i can't say the same for clorox.t still missed estimates, and the company warned about the guidance going forward as that pandemic boom fades, down 11% this moaning. alix: thank you very -- this morning. alix: thank you very much. coming up, we are going to delve deeper into earnings. chip demand for carmakers is huge. we will talk to the ceo of a major chip supplier for the auto industry. this is bloomberg. ♪ >> global semiconductor shortage has been impacting us. >> it has been quite a whipsaw for us in the industry. >> we are managing it week to week, day-to-day. >> the chip shortage will probably continue throughout 2022. there will be maybe some fluctuations in visibility. >> we are continually monitoring the situation and how we can anticipate the supply situation. >> it is out of our control, essentially. it does seem like it is getting better, but it is hard to predict. >> i think we have overcome chip shortages so far. we could manage, we could rearrange. >> it is something we will have to deal with for the

you look at some of these eli lillys of the world, the mercks of the world, you have strong dividendsre. i think it is looking like a value sector these days, and we think it is very interesting. u.s. ph just reported a very strong year. i also mentioned danaher. you look at something like abby, with 8 -- luck abbvie, with a yield over 4%. this is something to keep an eye on if you are nervous, and i am nervous. the big question is, are we going to have epsilon, gamma, lambda? if you are looking at some of these growthier names, i think the health care sector is a place you can hide. it is a place that can provide comfort as times get rocky. alix: so let's do that on a regional basis. you seemed to imply earlier that negative yields in europe are kind of going to put a cap and any yield rise in the u.s. you're definitely worried, so you want to find some sort of safety rather than growth. does that mean that u.s. exceptionalism theme that we saw continues versus rotating into europe or not? cate: i'm going to go with u.s. exceptionalism. i think the european economy may be quite stron

of names pfizer finally making all-time highs getting through that 43 1/2, 44 huge double top and eli lillyand that is the best in breed and that bio gen moving down to 325, the risk is for that that name so those are the three places would you continue to be. >> okay. karen what do you make of the moves and leslie pointed out these are a bit dated because it is as of june 30th so the positions could change but we pay attention to what berkshire does. >> because they're steady investors, they don't change that much. it has more impact i like the big cap pharma space. to lilly, bristol-myers and merck and pfizer and i think it is sort of been a nice place to hide in the storm of whether we're in growth or whether we're in delta variant, i feel like there is still upside there. the valuations are cheap the dividends are nice which i don't buy anything for dividends, but i like the space. i want to continue to hold onto it i think that one thing that we did see last year was people not going to the doctor, there was during the pandemic, they didn't go now hopefully they'll continue to go and t

eli lilly, bristle myers, xlb, quarter to long, it's the best sector >> farmer jim like brisal myers.th my final pick, but that's nxpi. nxpi is selling chips to the automotive industry. they're doing really well. >> thank you steve weiss, what do you got >> ttec iota, they had a great quarter, great numbers who knows what happens in the future they've split the company. they've exalted, the fundamental is strong. i want to point out reports tonight and moderna tomorrow morning. >> thanks everybody. you as well. "the exchange" is now. >>> thanks scott i am jon fortt in for kelly evans and here's what's ahead on "the exchange. the nasdaq holding on to a small gain, but robinhood soars on the return of meme mania perhaps we'll talk to a five-star fund manager and is refusing to get the covid vaccine the new smoking. health services secretary is going to join us to discuss how insurers should handle the unvaccinated and doing the pandemic pivot we will talk t

i bought eli lilly people are paying 34 times earnings for this one.s drug rolls back brain plaque and reduces symptoms of the horrifying disease in the future i agree with that. just so you know i agree with it. but if you look at the action in the stock, all the future is now. don't forget about regeneron the stock is successful treatment for covid-19 that gets you out of the hospital much faster not long ago it was in the hot seat for charging a fortune for a drug i didn't hear any anti-regeneron he is positive about it too. that was done really fast. finally, there is avid it is sneaky it moved up in anticipation of the rheumatoid arthritis drug getting fda approval for another type of arthritis. it is causing this one to trade at such a low price. i guess they have maybe -- i would say it is the lowest multiple and highest dividends you can see all of our moves before we make them by joining me actionalerts.com club i think the drug rally which faltered hard today is an opportunity because it is far from over. given the relative low valuations and

so another 28% of companies in the s p 500 report this week like uber take to eli lilly. beyond me. some the story. stocks and speak last week was big tech titans this week. it's more the story stocks. okay. >> and then i guess with the clock ticking towards the end of summer year. a finding that a lot of folks are trying to at least travel or spend time with family trying to get that in before the summer is gone. >> yeah. i mean, you and i both have kids. we know the importance of get the summer travel in early later on is try to get them sent other scheduled for the fall right. not this year. it's pack in every single minute of last minute end of summer pushing well. it's good for the travel industry. we're back to a pandemic levels. prepandemic levels of may of 2019 that were seen these late in august. so it looks like it's going to start a blowout summer travel. everyone squeeze number one reason the trial is family reunions. see a friend, a second birthdays anniversaries 3rd and we're going to tropical cities, mostly and then it turns into like an ventures and resorts relaxatio

today, we hear interactive and we get numbers from eli lilly and uber and many others for more, let's bring in valerie grant at allalliance bernstein valerie, you watch the markets push higher even with a down week last week you are still talking about the dow and s&p 1% away from the all-time high. it makes you wonder what knocks the market down. >> what would knock the markets down is weakness in earnings that is not what we're seeing. earnings season so far has been strong we had 59% of the and disruptio business models. that is what we are seeing in the numbers. >> so, we have the fed we know the meeting next month at jackson hole. jay powell seems to have said not so fast. that may not be where we announce something that is the one thing that would shake confidence if the fed would move sooner than later. >> it could have an effect on confidence that is very difficult to forecast i really try to stay really close to the fundamentals here what we are seeing, regardless of how rates are progressing, companies are investing in their businesses and looking at future growth opportunit

regeneron was the drug used for president trump when he got sick with covid eli lilly and the newestglaxosmithkline. saying early treatment can reduce hospitalization or death risk from covid by 70 to 85%, and they're indicated for people who are over 65 or have health conditions that put them at higher risk for severe disease these drugs have not been used that much until recently regeneron telling us before mid-july they were shipping about 25,000 doses per week. now that has gone up six fold to more than 160,000 doses per week their orders are up 300% saying the orders they have seen since july 1st, three quarters are coming from the area of the country with low vaccination rates. that red area in florida accounts for half of the courses ordered. veer ceo when he was on vacation last week to talk about what he's seeing in the trends. >> antibodies i think finally are getting the recognition that they deserve they really do reduce hospitalization and mortality dramatically the u.s., which had an oversupply for a while has the potential now to have an undersupply because the usage h

. >>> welcome back now a jam-packed day we'll marry from eli lilly, alibaba, under armour, nikolae andnies edging closer to adjusted ebitda profitability and lyft has said it expects to hit that milestone in the current third quarter lyft shares are up some 15% thi return to office plans the company pushing back the date for employees by six months to february 2nd. back to you. >> deirdre bosa, thank you watch 11:00 a.m., reese witherspoon a deal to sell her media firm to a company backed by blackstone. a good one she has become a maven, not just an incredible actress. as we wrap up the show, final thoughts today an odd market day. spill into the close, not a lot of damage done beneath the surface, though, potentially worrisome finds looking at the economy ten-year yield falling to 115 selling around 117 that shows buying a bonds, nervousness there, saw it in europe, german ten-year going more negative. crude oil bown 3.5%. protection against selling like the vix was higher. and then we married from the fed governor saying ready to tape irby october if we get a few good jobs reports. >

s&p 500, you have 64 new 52-week highs, leading that is the healthcare sector which 17, pfizer, eli lillyw highs and for the quarter, sara, it is healthcare that is so far is the leading sector i think that's indicative overall of the sentiment investors have toward the market. >> megan, can the yield moves continue to go on and be kind of disconnected from the stock market, which as sara mentioned is a point or two from record highs? >> yeah, i think this is one of the biggest disconnects that investors are grappling with right now. you have real yields that have rarely if ever been lower and yet the market is hitting an all time high. over nine to 12-month investment horizon we're optimistic we see the economy supported by consumer spending, capex, consumers were sitting on $3.5 trillion of excess saving and capex is back above prepandemic levels so we're constructive, but i would say the lower yields is signaling something very different from what we're seeing from earnings season, the ability of companies to pass on higher costs and maintain profit margins. at the end of the day, we t

eli lilly.tive momentum in the environment where the earnings he can expectations we muted. >> we will leave the conversation there kevin and joe, i appreciate it we will talk to you soon >>> when we come back, the white house making a big push on jobs. i spoke to the secretaries of commerce and labor about the new initiative the interview is coming up >>> we will make it a hat trick. transportation secretary pete buttigieg is with us "squawk box" will be right back. [engine revs] now let's go borrow a boat and make some bad decisions. [engine revs] time to go incognito. [zippers fasten] [engine revs] i love you, ricky! i love you, cal! what's the next stop? it's time for your extracurriculars. ¡vámanos, amigos! woo-hoo! ♪ music ♪ ♪ dream, dream when you're yourfeeling blue ♪ars. ♪ dream, dream that's the thing to do ♪ ♪ music ♪ when you see value in all directions, you add value in all directions. accenture. let there be change. this is hannah, she's a posh virtual receptionist at the ready 24-

>> eli lilly. a big drugmaker. people don't need therapeutics. you are looking at clorox. >> last year, hard to find any clorox wipes. that is tough for this company. this company said we fell short when it comes to sales and profit. the outlook for the year. 2020 for clorox. stuart: we were wiping everything down. not so much now, 88 points. >> everything is being wiped down now. those trends continue, even though it is not translated for covid i know. stuart: videogamemakers way down this morning becoming a target in china's crackdown and we don't know when it will end. >> 10 sent is the largest videogame distributor in china and part of this article from the propaganda machine, the government calling the addictive and comparing it to opium. stuart: opiate for the brain. >> they are taking down these game publishers and we have taken him to interact of the labor titles, weaker outlook than anticipated and we will look at what activevision blizzard does, the pandemic been might be slowing down. and mobile games. we when china wants control of in